Changes in liver polyribosome patterns following administration of hydrocortisone and actinomycin D.
D000315:Adrenalectomy; D000818:Animals; D001647:Bile Acids and Salts; D001835:Body Weight; D002499:Centrifugation, Density Gradient; D002501:Centrifugation, Zonal; D003609:Dactinomycin / Q000494:pharmacology*; D005215:Fasting; D006854:Hydrocortisone / Q000494:pharmacology*; D007106:Immune Sera; D008099:Liver / Q000032:analysis / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D046911:Macromolecular Substances; D008297:Male; D009929:Organ Size; D010756:Phosphoric Acids / Q000494:pharmacology; D012313:RNA / Q000032:analysis; D011817:Rabbits; D051381:Rats; D012260:Ribonucleases / Q000032:analysis; D012270:Ribosomes / Q000187:drug effects* / Q000378:metabolism; D013053:Spectrophotometry; D014466:Ultraviolet Rays
D001647:Bile Acids and Salts; D007106:Immune Sera; D046911:Macromolecular Substances; D010756:Phosphoric Acids; D003609:Dactinomycin; D012313:RNA; D012260:Ribonucleases; D006854:Hydrocortisone